作为KRAS抑制剂的新型Pyrido[4,3-d]pyrimidine化合物
1Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
ACS medicinal chemistry letters
|September 17, 2025
概括
新型的pyrido-[4,3-d]-pyrimidine化合物显示出作为基尔斯大鼠肉瘤病毒性瘤基因同类物 (KRAS) 的抑制剂的前景. 这些化合物为KRAS相关的癌症提供了潜在的新疗法.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 基尔斯顿大鼠肉瘤病毒瘤基因同类物 (KRAS) 在各种癌症中经常发生突变.
- 向KRAS是癌症治疗中的一个重大挑战.
- 开发新的KRAS抑制剂对于有效的癌症治疗至关重要.
研究的目的:
- 为了引入新的替代性化物-[4,3-d]-化物化合物.
- 评估这些化合物作为潜在的KRAS抑制剂.
- 探索它们在治疗包括癌症在内的KRAS相关疾病中的应用.
主要方法:
- 新型化物-[4,3-d]-胺基衍生物的合成.
- 在体外测试以评估KRAS抑制.
- 对潜在的治疗应用进行药理学评估.
主要成果:
- 特定的替代化物-[4,3-d]-化物化合物的鉴定.
- 证明了对KRAS的抑制活性.
- 这些化合物在制药成分中的潜力.
结论:
- 新型的pyrido-[4,3-d]-pyrimidine化合物代表了一个有前途的类型的KRAS抑制剂.
- 这些发现支持对KRAS驱动的癌症开发新的治疗策略.
- 需要进一步的研究来优化这些化合物用于临床使用.
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
The Ras Gene
7.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
589
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
589
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
M-Cdk Drives Transition Into Mitosis
6.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K


